HIMS Options +363%: Novo Nordisk Partnership Alert Win
HIMS Explodes 363% on Novo Nordisk Partnership: PPP Alert Case Study
Hims & Hers Health (HIMS) rocketed over 47% Monday morning after announcing a game-changing partnership with Novo Nordisk to distribute branded Ozempic and Wegovy weight-loss drugs through its telehealth platform. The deal resolves a bitter legal dispute and opens massive revenue opportunities in the red-hot GLP-1 market.
Pure Power Picks saw this reversal opportunity coming. PPP alerted HIMS $20 CALLs (April 16 expiration) at $1.03 on February 24, 2026, when the stock was trading around $15. The analyst’s thesis was clear: “Potential reversal play. Look for move into $17.5 – 20 for near term return to mean. Potential for HIMS to climb back into $22.5 – 25+ with time for maximum opportunities before expiration.”
With HIMS now trading at $22.18 and the options hitting a high of $4.77, this alert delivered a maximum opportunity of +363%. The near-term price targets of $17.5 and $20 have both been hit, validating the original technical analysis.
“Potential reversal play. Look for move into $17.5 – 20 for near term return to mean. Potential for HIMS to climb back into $22.5 – 25+ with time for maximum opportunities before expiration. Look for support to hold $15 – 14. A close under $13.75 voids this thesis.”
near term move – low end ✓
near term move – high end ✓
longer term target – low end
longer term target – high end
PPP identified HIMS as a reversal play with clear technical levels and price targets. The Novo Nordisk partnership catalyst aligned perfectly with the thesis, driving the stock through both near-term targets and delivering a 363% maximum opportunity on the options.
What Was the PPP Alert Thesis?
The PPP analyst identified HIMS as a classic reversal opportunity when the stock was trading in the $14-$15 alert zone. The technical setup suggested a “return to mean” move was likely, with clear upside targets mapped out.
The thesis centered on a bounce from key support levels. The analyst identified the $15-$14 range as critical support that needed to hold. Below that, a close under $13.75 would void the entire thesis — a clear risk management level.
For upside targets, the analyst laid out a two-stage approach. Near-term targets of $17.5 to $20 represented the initial “return to mean” move. The $17.5 level also served as the breakout trigger — once HIMS cleared this resistance, the thesis would be validated.
Longer-term targets stretched to $22.5-$25, providing substantial runway for the April 16 expiration. This target structure gave traders multiple exit opportunities depending on their profit-taking strategy.
The $20 strike selection was strategic — positioned right at the high end of the near-term target range. This gave the options immediate value once the breakout trigger hit, while still providing leverage for the longer-term move to $22.5-$25.
What News Drove the Move?
The catalyst came in the form of a major partnership announcement between Hims & Hers and pharmaceutical giant Novo Nordisk. The deal allows HIMS to distribute branded Ozempic and Wegovy weight-loss drugs through its telehealth platform, settling a contentious legal dispute.
This partnership is significant for multiple reasons. First, it resolves the legal uncertainty that had been weighing on HIMS stock. The company had been selling compounded versions of these GLP-1 drugs, leading to legal challenges from Novo Nordisk.
More importantly, the partnership opens massive revenue opportunities. The demand for GLP-1 weight-loss drugs like Ozempic and Wegovy has been explosive, with chronic supply shortages. By gaining authorized access to distribute these branded medications, HIMS positions itself in one of the fastest-growing pharmaceutical markets.
The telehealth angle amplifies this opportunity. HIMS can now offer patients convenient access to these sought-after medications through its platform, combining the appeal of the drugs themselves with the convenience of telehealth delivery. This creates a powerful competitive moat in the weight-loss treatment space.
The news perfectly aligned with the PPP analyst’s reversal thesis. The technical setup suggested HIMS was oversold and due for a bounce, while this fundamental catalyst provided the fuel for a sustained move higher.
How Did the Options React?
The $20 CALLs exploded from the $1.03 alert price to a high of $4.77, representing the full +363% maximum opportunity. The move wasn’t immediate — it took two weeks for the options to gain meaningful traction, hitting +10% on February 25th.
The real acceleration came today with the news catalyst. The options jumped +532% in a single session, moving from around +25% to over +300% as the stock blasted through the $20 strike price. This demonstrates how implied volatility expansion can amplify gains.
Current option Greeks show a delta of 0.684, meaning the options are moving roughly 68 cents for every dollar move in HIMS stock. The high gamma of 0.047 suggests this delta will continue increasing as the stock moves further in-the-money.
The April 16 expiration provided the perfect timeline. With over a month remaining, theta decay of -0.037 wasn’t crushing the position. Meanwhile, the elevated implied volatility of 106.3% worked in favor of option holders as the stock made its explosive move.
Volume of 4,251 contracts against open interest of 5,600 shows significant trading activity. This liquidity made it easier for traders to enter and exit positions as the thesis played out.
What Can Traders Learn?
This alert demonstrates the power of thesis-driven trading. The PPP analyst didn’t just pick a direction — they identified specific support levels, breakout triggers, and price targets. This roadmap helped traders understand both the opportunity and the risks.
Strike selection matters enormously. The $20 strike was positioned at the high end of the near-term target range, providing immediate value once the breakout occurred while maintaining leverage for the longer-term move. This strategic positioning maximized the risk-reward ratio.
The importance of having a void level cannot be overstated. By identifying $13.75 as the thesis-killing level, traders had a clear exit strategy if the trade went wrong. This type of disciplined approach follows Options Industry Council guidelines for structured options trading that separates professional-grade alerts from random stock picks.
Frequently Asked Questions
How did PPP identify this reversal opportunity?
The analyst used technical analysis to identify HIMS as oversold with strong support in the $14-$15 range. The risk-reward setup was attractive with clear upside targets at $17.5-$20 and longer-term potential to $22.5-$25. The void level at $13.75 provided a defined risk parameter.
Why was the $20 strike selected?
The $20 strike was positioned at the high end of the near-term price target range. This gave the options immediate intrinsic value once HIMS broke above $20, while still providing substantial leverage for the longer-term targets of $22.5-$25. The strike selection balanced probability with profit potential.
What made this news catalyst so powerful?
The Novo Nordisk partnership resolved legal uncertainty while opening access to the massive GLP-1 weight-loss drug market. This combined fundamental improvement with the technical reversal setup, creating the perfect storm for a sustained move higher. The news validated the analyst’s thesis that HIMS was due for a significant bounce.
How does this compare to other PPP alerts?
This alert follows the same structured approach as other successful PPP calls, including detailed case studies like AEO’s +326% move. Each alert provides a complete thesis with entry zones, price targets, breakout triggers, and void levels — giving traders a full roadmap rather than just a ticker symbol.
Every PPP alert comes with a detailed thesis, price targets, support/resistance levels, and a void level — the full roadmap, not just a ticker.
Disclaimer: Pure Power Picks is not a licensed financial advisor. All content is for educational and informational purposes only and should not be considered investment advice. Options trading involves substantial risk of loss and is not suitable for all investors. Past alert performance does not guarantee future results.
The PPP Team brings decades of combined experience from some of the most well-known companies in the trading industry. Founded in 2020, Pure Power Picks delivers options trading education, scanner reviews, and trade alerts to help everyday traders develop real skills. Our content is strictly educational.